Our People

Driven by a shared desire to develop better cancer therapies, we are a highly skilled team of oncology drug developers and experts in click chemistry, with decades of experience in the biopharmaceutical industry.

Shasqi leadership team

José M. Mejía Oneto, MD, PhD

Chief Executive Officer

Steve Abella, MD

Chief Medical Officer

Mukul Agarwal, MBA

Chief Business Officer

Sebastian Sanchez de Lozada

SVP Finance & Operations

Travis Biechele, PhD

VP Research

Scientific Advisory Board

Elliott Levy MD 

Dr. Levy is an industry veteran with over 25 years of drug development experience in leadership roles at global pharmaceutical companies, including Amgen and Bristol-Myers Squibb. He is currently serving on several boards and is a venture partner at 5AM Ventures.

Pat LoRusso, DO, PhD (hc)  

A highly experienced oncologist and translational scientist with over 30 years of experience in drug development and clinical research. Dr. LoRusso is the president-elect of the American Association of Cancer Research (AACR).

Lisa Coussens PhD, MD (h.c.), FAACR, FAIO 

As an internationally heralded cancer biologist, Dr. Coussens  has made seminal contributions to the chronic inflammation, tumor immunology, and basic cancer biology fields. She is the Chairwoman of the Department of Cell, Developmental & Cancer Biology at Oregon Health & Science University, and the immediate past president of the American Association of Cancer Research (AACR).

Board of Directors

José M. Mejía Oneto, MD, PhD

Chief Executive Officer

Juan Jaen, PhD

Pam Klein, MD

Mark McCamish, MD, PhD

Strategic Advisors

Ronald W. Barrett, PhD

Scientist Entrepreneur

Pamela M. Klein, MD

Biotech Executive and Strategic Advisor

William J. Rieflin

Executive Chairman

Matthew Fust, MBA

Independent Advisor to
Life Sciences Companies